78O_PR The Role of Ap-1 in Endocrine-Resistant Breast Cancer
Luca Malorni(Azienda Usl Toscana Centro), Rachel Schiff(Baylor College of Medicine), C. Kent Osborne(Baylor College of Medicine), Meghana V. Trivedi(University of Houston), Chad J. Creighton(Baylor College of Medicine), Xiaoyong Fu(King University), Susan G. Hilsenbeck(Baylor College of Medicine), Mathieu Lupien(Ontario Institute for Cancer Research), Ilenia Migliaccio(Hospital of Prato), M Giuliano(Baylor College of Medicine)
Cited by 2
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k